BACE1 and Alzheimer disease: Changes, either increased or decreased, in BACE1 expression have been associated with pathological conditions, such as AD, memory loss, and disturbance in synaptic plasticity, indicating strict regulatory mechanism controlling its expression (Faghihi et al., 2008).